Table 2.
Clinical characteristics of RMMP and non-RMPP
| Clinical Features | Non-RMMP group (n = 17) | RMMP group (n = 31) | P value |
|---|---|---|---|
| Age (years) | 4.79 ± 3.2 | 4.79 ± 3.47 | 0.983 |
|
MP-DNA × 105 (copies/mL) |
7. 83 ± 1.78 | 35. 81 ± 12.48 | 0.005 |
| White blood cell count (× 10/L9) | 7.28 ± 5.93 | 7.64 ± 3.17 | 0.192 |
| Procalcitonin (ng/mL) | 1.75 ± 3.29 | 1.52 ± 1.89 | 0.628 |
| Ultrasensitive C-reactive protein (mg/mL) | 18.06 ± 31.09 | 45.83 ± 64.69 | 0.001 |
| Lactate dehydrogenase (U/L) | 495.29 ± 199.19 | 795.97 ± 721.94 | 0.219 |
| Duration of cough (days) | 13 ± 8.36 | 18.03 ± 7.49 | 0.007 |
| Fever duration (days) | 7.82 ± 5.05 | 13.39 ± 7.65 | 0.009 |
| Length of hospitalization (days) | 9.12 ± 3.35 | 17.16 ± 7.08 | 0.000 |
| Duration of macrolide application (days) | 4.71 ± 2.47 | 11.61 ± 3.58 | 0.000 |
| Time to fever remission after macrolide application (days) | 3.69 ± 3.32 | 6.48 ± 4.01 | 0.021 |
P > 0.05 indicates no statistically significant difference between the two groups, and P < 0.05 indicates a statistically significant difference between the two groups